Elotuzumab Injection

Anter

• Ma mua o ka loaʻa ʻana o ka pahu elotuzumab,
• Hiki i nā kīʻaha Elotuzumab ke hopena i nā hopena ʻaoʻao. E haʻi i kāu kauka inā koʻikoʻi kekahi o kēia mau ʻōuli a mai hele aku paha:
• Hiki i kekahi o nā hopena ʻaoʻao ke koʻikoʻi.Inā ʻoe e ʻike i kekahi o kēia mau ʻōuli a i ʻole nā ​​mea i helu ʻia i ka ʻaoʻao HOW, e kāhea koke i kāu kauka:

Hoʻohana ʻia ka hoʻopili ʻana ʻo Elotuzumab me lenalidomide (Revlimid) a me dexamethasone a i ʻole me pomalidomide (Pomalyst) a me dexamethasone e mālama ai i nā myeloma he nui (kahi ʻano maʻi ʻaʻai o ka iwi iwi) ʻaʻole i hoʻomaikaʻi maikaʻi ʻia me ka hoʻomaʻamaʻa a i ʻole i hoʻomaikaʻi ʻia ma hope o ka mālama ʻana me nā lāʻau ʻē aʻe. akā hoʻi mai ma hope. Aia kahi kuʻi ʻo Elotuzumab i loko o ka papa o nā lāʻau i kapa ʻia he monoclonal antibodies. Hana ia ma ke kōkua ʻana i ke kino e hoʻolohi a kū i ka ulu ʻana o nā hunaola maʻi ʻaʻai.

Hele mai ʻo Elotuzumab ma ke ʻano he pauka e kāwili ʻia me ka wai sterile a hāʻawi ʻia me ka intravenously (i kahi aa) e ke kauka a kahu hānai paha i kahi hoʻonohonoho olakino. Ke hoʻohana ʻia me ka lenalidomide a me dexamethasone hāʻawi pinepine ʻia i hoʻokahi manawa i kēlā me kēia pule no nā pōʻaiapuni 2 mua (ʻo kēlā me kēia pōʻaiapili he 28 lā manawa mālama) a laila hoʻokahi manawa i kēlā me kēia 2 pule. Ke hoʻohana ʻia me ka pomalidomide a me ka dexamethasone hāʻawi pinepine ʻia i hoʻokahi manawa i kēlā me kēia pule no nā pōʻaiapuni 2 mua (ʻo kēlā me kēia pōʻaiapili he 28 lā manawa mālama) a laila hoʻokahi manawa i kēlā me kēia 4 pule.

E nānā pono kahi kauka a kahu hānai paha iā ʻoe ke loaʻa nei ka infusion a ma hope o ka hoʻopili ʻana e ʻike pono ʻaʻole ʻoe i kahi hopena koʻikoʻi i ka lāʻau. Hāʻawi ʻia ʻoe i nā lāʻau ʻē aʻe e kōkua i ka pale ʻana i nā hopena i elotuzumab. E haʻi koke i kāu kauka a kahu hānai paha inā ʻike ʻoe i kekahi o nā ʻōuli e hiki ke hana ʻia i ka wā o ka infusion a i ʻole 24 mau hola ma hope o kou loaʻa ʻana o ka infusion: fever, chills, rash, dizziness, lightheadedness, hoʻolōʻihi ka puʻuwai, ʻeha ka umauma, paʻakikī ka hanu ʻana, a i ʻole ka liʻiliʻi o ka hanu.

Hiki i kāu kauka ke hōʻemi i kāu lāʻau o elotuzumab a i ʻole kūlohi a kūloko paha i kāu lāʻau. Aia kēia i ka maikaʻi o ka hana ʻana o ka lāʻau iā ʻoe a me nā hopena ʻē aʻe āu e ʻike ai. E haʻi pono i kāu kauka i kou ʻano i kou wā e mālama ai me elotuzumab.

E noi i kāu kauka lāʻau a kauka paha no kahi kope o ka ʻike a ka mea hana no ka mea maʻi.

Kau ʻia kēia lāʻau no nā hoʻohana ʻē aʻe; e noi i kāu kauka a kauka paha no ka ʻike hou aku.

Ma mua o ka loaʻa ʻana o ka pahu elotuzumab,

• e haʻi i kāu kauka a me kāu kauka lāʻau inā he maʻi ʻoe i ka elotuzumab, nā lāʻau ʻē aʻe, a i ʻole kekahi o nā mea hana i ka elotuzumab injection. E noi i kāu kauka lāʻau a nānā paha i ka ʻike hoʻomanawanui o ka mea hana no kahi papa inoa o nā mea hoʻohui.
• e haʻi i kāu kauka a me ka mea kauka lāʻau i nā lāʻau lapaʻau, nā wikamina, nā mea hoʻopihapiha, a me nā huahana lāʻau āu e lawe nei a hoʻolālā paha e lawe. Pono paha kāu kauka e hoʻololi i nā kaha o kāu mau lāʻau a nānā pono iā ʻoe no nā hopena ʻaoʻao.
• e haʻi i kāu kauka inā loaʻa ʻoe i ka maʻi ʻaʻai a inā he maʻi maʻi ate paha kāu.
• E haʻi i kāu kauka inā hāpai ʻoe, e hoʻolālā e hāpai, a i ʻole e hānai umauma ana. Inā hāpai ʻoe i ka loaʻa ʻana o ka pahu elotuzumab, kāhea i kāu kauka.

Inā ʻaʻole haʻi kāu kauka iā ʻoe, e hoʻomau i kāu papaʻai maʻamau.

Hiki i nā kīʻaha Elotuzumab ke hopena i nā hopena ʻaoʻao. E haʻi i kāu kauka inā koʻikoʻi kekahi o kēia mau ʻōuli a mai hele aku paha:

• pāhoehoe
• kōpaʻa
• ʻeha poʻo
• ka luaʻi
• loli ke ʻano
• Kaumaha emi
• puhū pō
• numbness a i ʻole hoʻemi i ke ʻano o ka hoʻopā
• ʻeha iwi
• ʻūpē mākala
• pehu o kou mau lima a mau wāwae paha

Hiki i kekahi o nā hopena ʻaoʻao ke koʻikoʻi.Inā ʻoe e ʻike i kekahi o kēia mau ʻōuli a i ʻole nā ​​mea i helu ʻia i ka ʻaoʻao HOW, e kāhea koke i kāu kauka:

• ke anu, ka puʻu ʻeha, ke kuni, a me ka ʻūhā; pokole o ka hanu; ʻeha a puhi paha i ka urination; ʻāwīwī ʻeha; aiʻole nā ​​hōʻailona ʻē aʻe o ka maʻi
• numbness, nāwaliwali, ʻūlū, a i ʻole ʻeha mau ʻana i kou mau lima a me kou mau wāwae
• ʻeha ka umauma
• nausea, luhi nui loa a me ka nele o ka ikaika, nalo o ka makemake, melemele o ka ʻili a me nā maka, mimi ʻeleʻele, noho aliʻi pale, huikau, ʻeha ma ka ʻaoʻao ʻākau i luna o ka ʻōpū.
• loli ka hihiʻo

Hiki paha i ka elikōlū lūlū ke hoʻonui i kou makaʻu i ka hoʻomohala ʻana i kekahi mau maʻi ʻaʻai. E kamaʻilio me kāu kauka e pili ana i ka makaʻu o ka loaʻa ʻana o kēia lāʻau.

Hiki i nā kīʻaha Elotuzumab ke kumu i nā hopena ʻē aʻe. Kāhea i kāu kauka inā loaʻa iā ʻoe kekahi pilikia maʻamau i ka loaʻa ʻana o kēia lāʻau.

Inā ʻoe e ʻike i kahi hopena koʻikoʻi, e hoʻouna ʻoe a i ʻole kāu kauka i kahi hōʻike i ka papahana hōʻike ʻino a MedWatch Adverse Event Food (FDA) ma ka pūnaewele (http://www.fda.gov/Safety/MedWatch) a i ʻole kelepona. 1-800-332-1088).

E mālama i nā manawa a pau me kāu kauka a me ka hale hana. E kauoha kāu kauka i kekahi mau hoʻokolohua lab e nānā i ka pane o kou kino i ka elotuzumab injection.

Ma mua o ka hoʻāʻo ʻana i kahi lumi hoʻokolohua, e haʻi i kāu kauka a me nā limahana o ke keʻena hoʻokolohua ke loaʻa nei iā ʻoe ka elotuzumab injection.

E noi i kāu kauka lāʻau i nā nīnau āu e pili ana i ka elotuzumab injection.

He mea nui iā ʻoe e mālama i kahi papa inoa i kākau ʻia a me nā lāʻau lapaʻau ʻole (over-the-counter) lāʻau āu e lawe nei, a me nā huahana e like me nā huaora, nā minelala, a i ʻole nā ​​mea hoʻopiliʻai aʻe. Pono ʻoe e lawe i kēia papa inoa me ʻoe i kēlā me kēia manawa ke kipa ʻoe i ke kauka a i ʻole inā ʻae ʻia ʻoe i kahi haukapila. He ʻike nui nō hoʻi ia e lawe pū me ʻoe inā pilikia ʻo ka pilikia.

• Empliciti^®